Nuformix PLC
LSE:NFX

Watchlist Manager
Nuformix PLC Logo
Nuformix PLC
LSE:NFX
Watchlist
Price: 0.2 GBX -4.76%
Market Cap: £4.2m

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
£0
/
£0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
GBX0
/
£0

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Nuformix PLC
LSE:NFX
4.4m GBP
Loading...
US
Eli Lilly and Co
NYSE:LLY
977.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
545B USD
Loading...
CH
Roche Holding AG
SIX:ROG
279.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.5B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.2B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.9B USD
Loading...
FR
Sanofi SA
PAR:SAN
96B EUR
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Nuformix PLC
Glance View

Market Cap
4.2m GBX
Industry
Pharmaceuticals

Nuformix Plc is a pharmaceutical development company, which targets unmet medical needs in fibrosis and oncology via drug repurposing. The company is headquartered in Cambridge, Cambridgeshire and currently employs 3 full-time employees. The company went IPO on 2015-12-17. The firm focuses on medical needs in fibrosis and oncology using drug repurposing. Its clinical pipeline includes NXP001, NXP002 and NXP004. NXP001, is a form of the drug aprepitant that is marketed as a product in the oncology supportive care setting (chemotherapy induced nausea and vomiting). NXP002, is its pre-clinical lead asset and used for inhaled treatment for idiopathic pulmonary fibrosis (IPF). NXP004, is an oncology drug that is used for the treatment of several cancers. The firm's subsidiary is Nuformix Technologies Limited.

NFX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top